中医学报2017，Vol.32Issue(4)：507-509,3.DOI:10.16368/j.issn.1674-8999.2017.04.131
藤龙补中汤联合新辅助化疗治疗低位直肠癌临床研究
Clinical Research of Tenglong Buzhong Tang Combined with Neoadjuvant Chemotherapy in Treating Low Rectal Cancer
摘要
Abstract
Objective:To explore the clinical efficacy of Tenglong Buzhong Tang combined with neoadjuvant chemotherapy in treating low rectal cancer.Methods:42 cases of patients were randomly divided into the treatment group of 22 cases,and the control group of 20 cases.The control group was given Xelox programs neoadjuvant chemotherapy,and the treatment group was treated with Tenglong Buzhong Tang on the basis of neoadjuvant chemotherapy.Compared the KPS grade scores,CEA levels and alanine aminotransferase level of two groups before and after neoadjuvant chemotherapy,and compared the sphincter preservation rate after neoadjuvant chemotherapy.Results:The KPS grade scores on treatment group after neoadjuvant chemotherapy were significantly better than the control group.The CEA levels,and the alanine aminotransferase levels on the treatment group after neoadjuvant chemotherapy were significantly lower than control group after treatment (P ＜ 0.05).The rate of Sphincter preservation of the treatment group greater than the control group,but had no significant difference (P ＞ 0.05).Conclusion:Tenglong Buzhong Tang combined with neoadjuvant chemotherapy in treating low rectal cancer can improve the quality life of tumor patients significantly,lower the levels of tumor markers,protection the liver function.关键词
低位直肠癌/肿瘤/藤龙补中汤/新辅助化疗/中医药治疗/中西医结合Key words
low rectal cancer/tumor/Tenglong Buzhong Tang/neoadjuvant chemotherapy/TCM therapy/combination of traditional Chinese and Western medicine分类
医药卫生引用本文复制引用
董红兵,石变..藤龙补中汤联合新辅助化疗治疗低位直肠癌临床研究[J].中医学报,2017,32(4):507-509,3.基金项目
河南省医学科技攻关计划项目(201403227) （201403227）
